tiprankstipranks
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
US Market

Bioxcel Therapeutics (BTAI) Income Statement

Compare
1,384 Followers

Bioxcel Therapeutics Income Statement

Last quarter (Q3 2024), Bioxcel Therapeutics's total revenue was $214.00K, a decrease of -37.24% from the same quarter last year. In Q3, Bioxcel Therapeutics's net income was $-13.65M. See Bioxcel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.38M$ 375.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 120.00K$ 355.00K$ -297.00K$ -188.00K$ -156.00K
Operating Expenses
$ 171.90M$ 160.00M$ 106.94M$ 82.30M$ 33.60M
Depreciation and Amortization
$ 318.00K$ 327.00K$ 297.00K$ 188.00K$ 156.00K
EBITDA
$ -165.42M$ -157.38M$ -107.00M$ -81.98M$ -32.81M
Operating Income
$ -171.78M$ -159.65M$ -106.94M$ -82.30M$ -33.60M
Other Income/Expenses
$ -7.27M$ -6.11M$ -358.00K$ 128.00K$ 633.00K
Pretax Income
$ -179.05M$ -165.76M$ -106.93M$ -82.17M$ -32.97M
Net Income
$ -179.05M$ -171.85M$ -106.63M$ -82.01M$ -32.34M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.15$ -6.13$ -4.04$ -3.78$ -1.99
Diluted EPS
$ -6.15$ -6.13$ -4.04$ -3.78$ -1.99
Weighted Average Shares Outstanding
29.13M 28.02M 26.37M 21.68M 16.29M
Weighted Average Shares Outstanding (Diluted)
29.13M 28.02M 26.37M 21.68M 16.29M
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis